mAbxience2023-11-13T17:45:54+01:00

BIOPHARMACEUTICAL DEVELOPMENT

Experts in biologics, specialized in biosimilars

We are a leading vertically integrated biopharmaceuticals company, committed to improving patient access to treatments worldwide. Our in-house, core R&D competencies set us apart in the development of biosimilars and innovator biologics.

CDMO PLATFORM

End-to-end solutions to meet any manufacturing need

Thanks to our independent CDMO platform, we provide integrated services, adapted to your requirements: from research batches to commercial batches, big or small. We have over a decade of experience in the development and commercialization of biopharmaceuticals.

JOIN US!

Do you want to work at mAbxience?

WHAT’S NEW?

Catch up with our latest developments

The Future of Biosimilars: Trends and Predictions

Improving Drug Development: The Strategic Value of CDMO Partnerships

mAbxience and Biosidus Sign CDMO Agreement for the Manufacture of Agalsidase Beta for the Treatment of Fabry Disease

Go to Top